Connect your AI

Stereotaxis STXS Unrecognized tax benefits

Unrecognized tax benefits at other companies

Boston ScientificBSX

——

MedtronicMDT

——

ITG

Integer HoldingsITGR

——

Neuropace, Inc.NPCE

——

NVE CorporationNVEC

——

Other financials

Income statement

Revenue$6.3M-15.8%

Gross profit$3.8M-6.6%

Operating income-$6.0M-0.9%

Net income-$5.9M-0.7%

EPS (diluted)-$0.06+14.3%

Balance sheet

Cash & equivalents$14.6M+36.7%

Total debt$5.3M-10.0%

Total equity$14.4M+399%

Total assets$54.0M+18.2%

Cash flow

Operating cash flow-$3.4M-93.5%

CapEx$79.0K—

Free cash flow-$3.5M—

Valuation

Market cap$168.11M-11.6%

Enterprise value$158.77M-15.9%

P/S5.4×-0.6×

Profitability

Gross margin53.9%+0.5pp

Operating margin-71%-14.0pp

Net margin-69.5%-13.7pp

FCF margin-35.5%-2.4pp

Returns & leverage

Return on equity-251.5%-29.9pp

Debt / equity0.4×-1.7×

Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.

The official record: Stereotaxis’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's unrecognized tax benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Stereotaxis's unrecognized tax benefits?: Stereotaxis (STXS) reported unrecognized tax benefits of $100K in Q4 2025.